Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-020370
Filing Date
2021-05-21
Accepted
2021-05-21 17:21:46
Documents
2
Period of Report
2021-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2412
2 EX-24 DOCUMENT attachment1.htm EX-24 3675
  Complete submission text file 0000899243-21-020370.txt   7562
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE, 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Ho Peter Tai-Ching (Reporting) CIK: 0001619052 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36361 | Film No.: 21950271